Healthcare
Home » Oral Solid Dosage Contract Manufacturing Market

Oral Solid Dosage Contract Manufacturing Market

Oral Solid Dosage Contract Manufacturing Market By Type Outlook (Tablets, Capsules, Powders, Granules) By Mechanism Outlook (Immediate-release, Delayed-release, Controlled-release) – Growth, Future Prospects & Competitive Analysis, 2016 – 2030
Report Book

Published Date: Aug 2023
Category: Healthcare
Report ID: 62014
Report Format: PDF
No of Pages: 200

Rating: Credence Reports

Key Highlights of the Report

The global oral solid dosage contract manufacturing market is segmented by type outlook, mechanism outlook, end-user outlook, and region. Tablets’ oral solid dosage contract manufacturing is the most popular. Immediate release is the most commonly used mechanism outlooks, whereas large-size companies hold the maximum share, with Asia Pacific leading the market growth.

The global oral solid dosage contract manufacturing market has several drivers, including The market is growing as a result of rising investments by CDMOs to expand the development of oral solid dosage (OSD), increasing demand for innovative medicines, and the development of drug delivery technologies such as targeted drug delivery and sustained release dosage forms. It is quite unlikely that oral pharmaceutical items will ever be supplanted by new technology. New solid-dose formats and improved efficiency are driving the growth of solid-dose pharmaceutical manufacturing. However, the market also faces significant challenges, such as the Strict requirements for approval from regulatory authorities.

Nonetheless, the global oral solid dosage contract manufacturing market offers significant growth opportunities, including businesses already utilizing cutting-edge technologies to increase the bioavailability of dosage forms to increase patient compliance.

What Are The Main Drivers Of The Global Oral Solid dosage contract Manufacturing Market?

The global oral solid dosage contract manufacturing market is driven by several factors, including increasing investments by CDMOs to extend the development of oral solid dosages and the development of drug delivery technologies such as targeted drug delivery and sustained release dosage forms.

What Are The Major Challenges Faced By The Global Oral Solid dosage contract Manufacturing Market?

The global oral solid dosage contract manufacturing market also faces several challenges, including the strict regulatory authorities’ approval requirements.

What Are The Growth Opportunities In The Global Oral solid dosage contract manufacturing Market?

The global oral solid dosage contract manufacturing market offers significant growth opportunities, including businesses already utilizing cutting-edge technologies to increase the bioavailability of dosage forms to increase patient compliance.

Executive Summary

Overview of the Global Oral solid dosage contract manufacturing Market

The global oral solid dosage contract manufacturing market has been steadily growing in recent years, driven by the increasing investments by CDMOs to extend the development of oral solid dosages and the development of drug delivery technologies such as targeted drug delivery and sustained release dosage forms. The market is distinguished by a broad range of type outlooks, mechanism outlooks, and end-user outlooks that cater to various customer preferences.

Oral Solid dosage contract Manufacturing Market

Market Definition

Oral Solid Dosage Contract Manufacturing and the intricacy of new medication ingredients will all contribute to the market’s growth. Oral solids are the most often used dose forms in the pharmaceutical business because they are inexpensive, simple to make, and convenient for patients. Because of advances in drug delivery technology, such as pharmaceutical distribution and sustained-release formulation, oral solids can now achieve even higher levels of bioavailability while needing less frequent prescription administration. Tablets and capsules are the most basic forms of solid dosage forms.

Market Insights

  • The global demand for oral solid dosage contract manufacturing was valued at USD 32.5 Billion in 2022 and is expected to reach USD 49.8 Billion in 2030, growing at a CAGR of 6.30% between 2023 and 2030.
  • Tablets are the leading segment by type outlook and held over 32.7% share in terms of value in 2022, while the capsules segment is likely to exhibit the fastest CAGR during the forecast period.
  • The controlled-release segment governs the global demand for oral solid dosage contract manufacturing, holding a massive share of over 51.5% in 2022, and is expected to grow at a rapid CAGR.
  • The medium- & small-size companies segment is expected to post the highest CAGR during the forecast period, while the large-size companies segment is leading the market share with over 54.5% share in 2022.
  • Asia Pacific is fueling the growth of the oral solid dosage contract manufacturing industry with over one-third share in 2022, while North America and Europe collectively account for just under 50% share in 2022. Europe held over 22% share in 2022.
  • With much cheaper prices, India and China are APAC OSD CMO market powerhouses. As patents expire, generic medication production has become the APAC region’s second-largest revenue source. At the same time, strict requirements for approval from regulatory authorities are the main restraints.
  • Businesses are already utilizing cutting-edge technologies to increase the bioavailability of dosage forms to increase patient compliance are the major opportunities in the market.

Segmentation by Type Outlook

  • Tablets are the leading segment by type outlook and held over 32.7% share in terms of value in 2022.
  • The capsules segment will likely exhibit the fastest CAGR during the forecast period.

Segmentation by Mechanism Outlook

  • The controlled-release segment governs the demand for oral solid dosage contract manufacturing in the world, holding a massive share of over 51.5% in 2022, and is also expected to grow at a rapid CAGR.
  • The immediate-release segment contributes to the rest of the demand for oral solid dosage contract manufacturing.

Segmentation by End-user Outlook

  • The medium- & small-size companies segment is expected to post the highest CAGR during the forecast period.
  • The large-size companies segment is leading the market share with over 30% share in 2022.

Segmentation by Region

  • Asia Pacific is fueling the growth of the oral solid dosage contract manufacturing industry with over one-third share in 2022.
  • North America and Europe collectively account for just under 50% share in 2022, with Europe holding over 22% share in the same year.
  • The rest of the World, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for oral solid dosage contract manufacturing.

The increasing demand for oral solid dosage contract manufacturing can be attributed to the increasing investments by CDMOs to extend the development of oral solid dosages and the development of drug delivery technologies such as targeted drug delivery and sustained release dosage forms. However, the market is restrained by strict regulatory approval requirements.

The United States is one of the largest markets for oral solid dosage contract manufacturing in North America, with a significant share of the market. North America is the second-most profitable region because of investments by regional corporations and increased medicine approval by the FDA. For example, the FDA authorized 50 innovative medications in the United States alone in 2021, 22 of which were tablets or capsules. The United States continues to lead the OSD CMO market, owing to a sophisticated healthcare industry, a government focus on generics, and more funding availability. On the other hand, recent developments in drug delivery have enabled North American OSD manufacturers to attain significant bioavailability through novel drug delivery platforms. This is projected to enhance demand in the region for oral controlled-release medication delivery technology.

China is a significant market for the contract production of oral solid dosage in the Asia Pacific area, with a significant market share. With much cheaper prices, India and China are APAC OSD CMO market powerhouses. As patents expire, generic medication production has become the APAC region’s second-largest revenue source. CMOs also pursue ISO accreditation in environmental management, quality management, and energy consumption. Furthermore, while the number of warning letters has reduced in established markets, it has climbed in Asia Pacific, and the bulk of recalls result from cGMP manufacturing standards violations.

Overall, the increasing demand for oral solid dosage contract manufacturing can be attributed to the increasing investments by CDMOs to extend the development of oral solid dosages and the development of drug delivery technologies such as targeted drug delivery and sustained release dosage forms. Businesses are already utilizing cutting-edge technologies to increase the bioavailability of dosage forms to increase patient compliance.

While the oral solid dosage contract manufacturing market is growing, it faces challenges from strict requirements for approval from regulatory authorities. Manufacturers are innovating and forming partnerships to stay competitive.

High Demand for Oral Solid Dosage Contract Manufacturing Due to Its Key Benefits

To protect and treat the afflicted population worldwide, the prevalence of viral and chronic diseases is rising. Pharmaceutical goods are cures or therapies from metabolites naturally occurring in living things. The extensive need for the large-scale production of innovative treatments has been caused by the widespread usage of pharmaceutical drugs by patients suffering from various ailments.

Major pharmaceutical corporations are progressively outsourcing contract manufacturing as the need for large-scale production increases. As a result, as demand for innovative medicines rises, so will the need for oral solid dose contract manufacturing.

Rising economic prosperity and greater health awareness will also foster market growth in the coming years. Businesses focus on acquiring and merging with others to increase their market share and profit from shared technology. The cost of manufacturing is always growing. To establish long-term contract manufacturing arrangements, big and small pharma and biotech companies are focusing on CDMOs. This will help businesses maintain set manufacturing rates, and CDMOs improve manufacturing quality.

Strict Requirements for Approval from Regulatory Authorities

Every nation has a sizable number of rules established by regulatory bodies. Additionally, small CDMOs that lack cutting-edge machinery are more likely to have rising process errors, subpar quality, and problems with pricing. The approval of small molecules has decreased in industrialized nations due to the strict regulations established by regulatory organizations, which has slowed the market growth for contract development and manufacture.

Many small and large CDMOs employ various strategies to strengthen their market positions, including manufacturing expansion, partnerships, mergers, and acquisitions. In October 2021, Lonza, for instance, increased the scope of its mammalian product development services in Singapore.

Most pharma and biotech companies grant contracts to CDMOs in developing nations because these nations have lower development costs than industrialized nations. Time zones, linguistic barriers, and cultural variations can all slow communication and postpone product delivery.

There Is Fierce Competition In The Market For Oral Solid Dose Contracts.

The oral solid dosage contract manufacturing industry is extremely competitive as incumbent service providers increase their service portfolios, and some internal pharmaceutical operations are being transformed to offer CMO services. Additionally, contract manufacturers’ clientele is shrinking due to the pharmaceutical industry’s growing consolidation.  Oral solid dose contract manufacturers are actively working to improve their offers to compete with the escalating market rivalry by producing goods of high and consistent quality while meeting the various needs of sponsor companies.

Developments in Oral Solid Dosage Forms Technology

Many profitable prospects for oral solid dose contract manufacturing enterprises worldwide are expected during the projection period. These firms can focus on technological advancements in oral solid dosage forms to improve their stability, yield, bioavailability, and morphological characteristics. They can also develop different oral solid dosage forms such as enteric-coated, extended-release, controlled release, and others.

Catalent’s Biologics sector, for example, provides cell-line development using the company’s GPEx Boost platform. The GPEx platform facilitates the development of robust, high-yielding mammalian cell lines for biosimilars.

Despite these advancements, there are still several drawbacks, such as the market’s continued fragmentation and numerous small CMOs, which prevent them from being a single leading provider of pharmaceutical solid dose contract manufacturing. Consolidation has a great chance to occur, which can help businesses with higher operating margins and greater possibilities for market expansion.

Contract manufacturing and development companies might also focus on developing flexible business models. A flexible business strategy will attract large and small pharma and biotech companies.

Many CDMOs develop oral solid dosage forms using the particle engineering technique. By purchasing this technology, CDMOs might be able to increase their market share.

Competitive Landscape

Key Players

The global oral solid dosage contract manufacturing market is highly competitive, with the presence of several key players. Some of the major players in the market and their market share are as follows:

  • Catalent Inc
  • Lonza Group
  • Piramal Pharma Solutions
  • Aenova
  • Jubilant
  • Boehringer Ingelheim
  • AbbVie Contract Manufacturing
  • Patheon
  • Recipharm
  • Next Pharma AB
  • Siegfried AG
  • Corden Pharma

These companies focus on product innovation, expanding their End-user Outlooks, and mergers and acquisitions to stay ahead in the market.

The major players in the global oral solid dosage contract manufacturing market constantly strive to stay ahead by introducing new products and innovations.

Aurobindo purchased the dermatological and oral solids divisions of Sandoz Inc., a U.S. company, in September 2018. This will help Sandoz achieve sustainable and profitable growth in the United States by concentrating on complicated generics, value-added medications, and biosimilars.

According to Piramal Pharma Solutions (PPS), a leading CDMO, a new wing at the Riverview plant dedicated to the production of High Potency Active Pharmaceutical Ingredients (HPAPIs) with Low Occupational Exposure Levels (OELs) was officially opened in June 2019.

Piramal Enterprises Ltd. purchased the Sellersville, Pennsylvania, manufacturing facility for oral solid dose medicinal products from G&W Laboratories Inc. in June 2020. With the addition of oral solid dosage form (tablets and capsules) capabilities through this acquisition, the Piramal Pharma Solutions (PPS) product range in North America is expanded.

Summary of Key Findings

  • Increasing investments by CDMOs to extend the development of oral solid dosages and drug delivery technologies such as targeted drug delivery and sustained release dosage forms are driving the market growth.
  • Market segmented by type outlook, mechanism outlook, end-user outlook, and region.
  • Tablets oral solid dosage contract manufacturing are the most popular, with capsules as primary user segments.
  • Controlled release is most commonly used for mechanism outlook.
  • Large-size Companies hold the highest revenue in the forecast period.
  • Asia Pacific is leading market growth; the market is highly competitive with key players including Catalent Inc; Lonza Group; Piramal Pharma Solutions; Aenova; Jubilant; Boehringer Ingelheim; AbbVie Contract Manufacturing; Patheon; Recipharm; Next Pharma AB; Siegfried AG; Corden Pharma.

Future Outlook

  • Positive outlook for the global oral solid dosage contract manufacturing market with significant growth potential in the Asia Pacific region
  • Businesses are already utilizing cutting-edge technologies to increase the bioavailability of dosage forms to increase patient compliance to drive growth.
  • Challenges from the strict requirements for approval from regulatory authorities
  • Key players to focus on product innovation, expanding market reach and maintaining competitive pricing to stay ahead in the market.

Segmentation

  • By Type Outlook
    • Tablets
    • Capsules
    • Powders
    • Granules
    • Others (Lozenges, Gummies, Pastilles, etc.)
  • By Mechanism Outlook
    • Immediate-release
    • Delayed-release
    • Controlled-release
  • By End-user Outlook
    • Large-size Companies
    • Medium- & Small-size Companies
    • Others (Startups & Generic Pharmaceutical Companies)
  • By Region
  • North America
    • The US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Oral Solid Dosage Contract Manufacturing Market
2.2. Global Oral Solid Dosage Contract Manufacturing Market, By Type Outlook
2.3. Global Oral Solid Dosage Contract Manufacturing Market, By Mechanism Outlook
2.4. Global Oral Solid Dosage Contract Manufacturing Market, By End-user Outlook
2.5. Global Oral Solid Dosage Contract Manufacturing Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Oral Solid Dosage Contract Manufacturing Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Smart Shopping Market Drivers
3.2.2. Smart Shopping Market Restraints
3.2.3. Smart Shopping Market Opportunities
3.2.4. Major Smart Shopping Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type Outlook
3.5.2. Mechanism Outlook
3.5.3. End-user Outlook
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Type Outlook Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Oral Solid Dosage Contract Manufacturing Market, By Type Outlook
7.1. Global Oral Solid Dosage Contract Manufacturing Market Overview, by Type Outlook
7.1.1. Global Oral Solid Dosage Contract Manufacturing Market Revenue Share, By Type Outlook, 2022 Vs 2030 (in %)
7.2. Tablets
7.2.1. Global Oral Solid Dosage Contract Manufacturing Market, By Region, 2017-2030 (US$ Mn)
7.3. Capsules
7.3.1. Global Oral Solid Dosage Contract Manufacturing Market, By Region, 2017-2030 (US$ Mn)
7.4. Powders
7.4.1. Global Oral Solid Dosage Contract Manufacturing Market, By Region, 2017-2030 (US$ Mn)
7.5. Granules
7.5.1. Global Oral Solid Dosage Contract Manufacturing Market, By Region, 2017-2030 (US$ Mn)
7.6. Others
7.6.1. Global Oral Solid Dosage Contract Manufacturing Market, By Region, 2017-2030 (US$ Mn)

8. Global Oral Solid Dosage Contract Manufacturing Market, By Mechanism Outlook
8.1. Global Oral Solid Dosage Contract Manufacturing Market Overview, by Mechanism Outlook
8.1.1. Global Oral Solid Dosage Contract Manufacturing Market, By Mechanism Outlook, 2022 vs 2030 (in %)
8.2. Immediate-release
8.2.1. Global Oral Solid Dosage Contract Manufacturing Market, By Region, 2017-2030 (US$ Mn)
8.3. Delayed-release
8.3.1. Global Oral Solid Dosage Contract Manufacturing Market, By Region, 2017-2030 (US$ Mn)
8.4. Controlled-release
8.4.1. Global Oral Solid Dosage Contract Manufacturing Market, By Region, 2017-2030 (US$ Mn)

9. Global Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2030 (US$ Mn)
9.1. Global Oral Solid Dosage Contract Manufacturing Market Overview, by End-user Outlook
9.1.1. Global Oral Solid Dosage Contract Manufacturing Market, By End-user Outlook, 2022 vs 2030 (in%)
9.2. Large-size Companies
9.2.1. Global Oral Solid Dosage Contract Manufacturing Market, By Region, 2017-2030 (US$ Mn)
9.3. Medium- & Small-size Companies
9.3.1. Global Oral Solid Dosage Contract Manufacturing Market, By Region, 2017-2030 (US$ Mn)
9.4. Others
9.4.1. Global Oral Solid Dosage Contract Manufacturing Market, By Region, 2017-2030 (US$ Mn)

10. Global Oral Solid Dosage Contract Manufacturing Market, By Region
10.1. Global Oral Solid Dosage Contract Manufacturing Market Overview, by Region
10.1.1. Global Oral Solid Dosage Contract Manufacturing Market, By Region, 2022 vs 2030 (in%)
10.2. Type Outlook
10.2.1. Global Oral Solid Dosage Contract Manufacturing Market, By Type Outlook, 2017-2030 (US$ Mn)
10.3. Mechanism Outlook
10.3.1. Global Oral Solid Dosage Contract Manufacturing Market, By Mechanism Outlook, 2017-2030 (US$ Mn)
10.4. End-user Outlook
10.4.1. Global Oral Solid Dosage Contract Manufacturing Market, By End-user Outlook, 2017-2030 (US$ Mn)

11. North America Oral Solid Dosage Contract Manufacturing Market Analysis
11.1. North America Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2030(US$ Mn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. North America Oral Solid Dosage Contract Manufacturing Market, by Mechanism Outlook, 2017-2030(US$ Mn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. North America Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2030(US$ Mn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. North America Oral Solid Dosage Contract Manufacturing Market, by Country, 2017-2030 (US$ Mn)
11.4.1. North America Oral Solid Dosage Contract Manufacturing Market, by Country, 2022 Vs 2030 (in%)
11.4.2. U.S.
11.4.2.1. U.S. Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
11.4.2.2. U.S. Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
11.4.2.3. U.S. Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
11.4.2.4. U.S. Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
11.4.3. Canada
11.4.3.1. Canada Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
11.4.3.2. Canada Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
11.4.3.3. Canada Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
11.4.3.4. Canada Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
11.4.4. Mexico
11.4.4.1. Mexico Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
11.4.4.2. Mexico Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
11.4.4.3. Mexico Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
11.4.4.4. Mexico Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)

12. Europe Oral Solid Dosage Contract Manufacturing Market Analysis
12.1. Europe Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2030(US$ Mn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Europe Oral Solid Dosage Contract Manufacturing Market, by Mechanism Outlook, 2017-2030(US$ Mn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Europe Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2030(US$ Mn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Europe Oral Solid Dosage Contract Manufacturing Market, by Country, 2017-2030 (US$ Mn)
12.4.1. Europe Oral Solid Dosage Contract Manufacturing Market, by Country, 2022 Vs 2030 (in%)
12.4.2. Germany
12.4.2.1. Germany Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
12.4.2.2. Germany Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
12.4.2.3. Germany Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
12.4.2.4. Germany Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
12.4.3. France
12.4.3.1. France Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
12.4.3.2. France Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
12.4.3.3. France Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
12.4.3.4. France Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
12.4.4. UK
12.4.4.1. UK Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
12.4.4.2. UK Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
12.4.4.3. UK Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
12.4.4.4. UK Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
12.4.5. Italy
12.4.5.1. Italy Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
12.4.5.2. Italy Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
12.4.5.3. Italy Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
12.4.5.4. Italy Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
12.4.6. Spain
12.4.6.1. Spain Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
12.4.6.2. Spain Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
12.4.6.3. Spain Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
12.4.6.4. Spain Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
12.4.7. Rest of Europe
12.4.7.1. Rest of Europe Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
12.4.7.2. Rest of Europe Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
12.4.7.3. Rest of Europe Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
12.4.7.4. Rest of Europe Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)

13. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Analysis
13.1. Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2030(US$ Mn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Mechanism Outlook, 2017-2030(US$ Mn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2030(US$ Mn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Country, 2017-2030 (US$ Mn)
13.4.1. Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Country, 2022 Vs 2030 (in%)
13.4.2. China
13.4.2.1. China Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
13.4.2.2. China Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
13.4.2.3. China Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
13.4.2.4. China Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
13.4.3. Japan
13.4.3.1. Japan Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
13.4.3.2. Japan Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
13.4.3.3. Japan Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
13.4.3.4. Japan Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
13.4.4. India
13.4.4.1. India Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
13.4.4.2. India Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
13.4.4.3. India Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
13.4.4.4. India Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
13.4.5. South Korea
13.4.5.1. South Korea Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
13.4.5.2. South Korea Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
13.4.5.3. South Korea Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
13.4.5.4. South Korea Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
13.4.6. South-East Asia
13.4.6.1. South-East Asia Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
13.4.6.2. South-East Asia Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
13.4.6.3. South-East Asia Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
13.4.6.4. South-East Asia Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
13.4.7. Rest of Asia Pacific
13.4.7.1. Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
13.4.7.2. Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
13.4.7.3. Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
13.4.7.4. Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)

14. Latin America Oral Solid Dosage Contract Manufacturing Market Analysis
14.1. Latin America Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2030(US$ Mn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Latin America Oral Solid Dosage Contract Manufacturing Market, by Mechanism Outlook, 2017-2030(US$ Mn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Latin America Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2030(US$ Mn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Latin America Oral Solid Dosage Contract Manufacturing Market, by Country, 2017-2030 (US$ Mn)
14.4.1. Latin America Oral Solid Dosage Contract Manufacturing Market, by Country, 2022 Vs 2030 (in%)
14.4.2. Brazil
14.4.2.1. Brazil Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
14.4.2.2. Brazil Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
14.4.2.3. Brazil Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
14.4.2.4. Brazil Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
14.4.3. Argentina
14.4.3.1. Argentina Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
14.4.3.2. Argentina Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
14.4.3.3. Argentina Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
14.4.3.4. Argentina Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
14.4.4. Rest of Latin America
14.4.4.1. Rest of Latin America Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
14.4.4.2. Rest of Latin America Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
14.4.4.3. Rest of Latin America Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
14.4.4.4. Rest of Latin America Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)

15. Middle East and Africa Oral Solid Dosage Contract Manufacturing Market Analysis
15.1. Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2030(US$ Mn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by Mechanism Outlook, 2017-2030(US$ Mn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2030(US$ Mn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by Country, 2017-2030 (US$ Mn)
15.4.1. Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by Country, 2022 Vs 2030 (in%)
15.4.2. GCC Countries
15.4.2.1. GCC Countries Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
15.4.2.2. GCC Countries Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
15.4.2.3. GCC Countries Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
15.4.2.4. GCC Countries Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
15.4.3. South Africa
15.4.3.1. South Africa Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
15.4.3.2. South Africa Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
15.4.3.3. South Africa Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
15.4.3.4. South Africa Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)
15.4.4. Rest of Middle East and Africa
15.4.4.1. Rest of Middle East and Africa Oral Solid Dosage Contract Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Mn)
15.4.4.2. Rest of Middle East and Africa Oral Solid Dosage Contract Manufacturing, By Type Outlook, 2017-2030 (US$ Mn)
15.4.4.3. Rest of Middle East and Africa Oral Solid Dosage Contract Manufacturing, By Mechanism Outlook, 2017-2030 (US$ Mn)
15.4.4.4. Rest of Middle East and Africa Oral Solid Dosage Contract Manufacturing, By End-user Outlook, 2017-2030 (US$ Mn)

16. Company Profiles
16.1. Catalent Inc
16.1.1. Company Overview
16.1.2. Products/Services Portfolio
16.1.3. Geographical Presence
16.1.4. Financial Summary
16.1.4.1. Market Revenue and Net Profit (2019-2022)
16.1.4.2. Business Segment Revenue Analysis
16.1.4.3. Geographical Revenue Analysis
16.2. Lonza Group
16.3. Piramal Pharma Solutions
16.4. Aenova
16.5. Jubilant
16.6. Boehringer Ingelheim
16.7. AbbVie Contract Manufacturing
16.8. Patheon
16.9. Recipharm
16.10. Next Pharma AB
16.11. Siegfried AG
16.12. Corden Pharma

List of Figures
FIG. 1 Global Oral Solid Dosage Contract Manufacturing Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Oral Solid Dosage Contract Manufacturing Market Segmentation
FIG. 4 Global Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2022 (US$ Mn)
FIG. 5 Global Oral Solid Dosage Contract Manufacturing Market, by Mechanism Outlook, 2022 (US$ Mn)
FIG. 6 Global Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2022 (US$ Mn)
FIG. 7 Global Oral Solid Dosage Contract Manufacturing Market, by Geography, 2022 (US$ Mn)
FIG. 8 Attractive Investment Proposition, by Type Outlook, 2022
FIG. 9 Attractive Investment Proposition, by Mechanism Outlook, 2022
FIG. 10 Attractive Investment Proposition, by End-user Outlook, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Oral Solid Dosage Contract Manufacturing Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Oral Solid Dosage Contract Manufacturing Market Manufacturers, 2022
FIG. 14 Global Oral Solid Dosage Contract Manufacturing Market Value Contribution, By Type Outlook, 2022 & 2030 (Value %)
FIG. 15 Global Oral Solid Dosage Contract Manufacturing Market, by Tablets, Value, 2017-2030 (US$ Mn)
FIG. 16 Global Oral Solid Dosage Contract Manufacturing Market, by Capsules, Value, 2017-2030 (US$ Mn)
FIG. 17 Global Oral Solid Dosage Contract Manufacturing Market, by Powders, Value, 2017-2030 (US$ Mn)
FIG. 18 Global Oral Solid Dosage Contract Manufacturing Market, by Granules, Value, 2017-2030 (US$ Mn)
FIG. 19 Global Oral Solid Dosage Contract Manufacturing Market, by Others, Value, 2017-2030 (US$ Mn)
FIG. 20 Global Oral Solid Dosage Contract Manufacturing Market Value Contribution, By Mechanism Outlook, 2022 & 2030 (Value %)
FIG. 21 Global Oral Solid Dosage Contract Manufacturing Market, by Immediate-release, Value, 2017-2030 (US$ Mn)
FIG. 22 Global Oral Solid Dosage Contract Manufacturing Market, by Delayed-release, 2017-2030 (US$ Mn)
FIG. 23 Global Oral Solid Dosage Contract Manufacturing Market, by Controlled-release, 2017-2030 (US$ Mn)
FIG. 24 Global Oral Solid Dosage Contract Manufacturing Market Value Contribution, By End-user Outlook, 2022 & 2030 (Value %)
FIG. 25 Global Oral Solid Dosage Contract Manufacturing Market, by Large-size Companies, Value, 2017-2030 (US$ Mn)
FIG. 26 Global Oral Solid Dosage Contract Manufacturing Market, by Medium- & Small-size Companies, 2017-2030 (US$ Mn)
FIG. 27 Global Oral Solid Dosage Contract Manufacturing Market, by Others, 2017-2030 (US$ Mn)
FIG. 28 North America Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 29 U.S. Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 30 Canada Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 31 Europe Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 32 Germany Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 33 France Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 34 U.K. Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 35 Italy Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 36 Spain Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 37 Rest of Europe Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 38 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 39 China Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 40 Japan Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 41 India Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 42 South Korea Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 43 South-East Asia Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 44 Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 45 Latin America Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 46 Brazil Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 47 Mexico Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 48 Rest of Latin America Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 49 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 50 GCC Countries Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 51 South Africa Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)
FIG. 52 Rest of Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, 2017-2030 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Oral Solid Dosage Contract Manufacturing Market
TABLE 2 Global Oral Solid Dosage Contract Manufacturing Market: Market Drivers Impact Analysis
TABLE 3 Global Oral Solid Dosage Contract Manufacturing Market: Market Restraints Impact Analysis
TABLE 4 Global Oral Solid Dosage Contract Manufacturing Market, by Competitive Benchmarking, 2022
TABLE 5 Global Oral Solid Dosage Contract Manufacturing Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Oral Solid Dosage Contract Manufacturing Market, by Key Strategies Analysis, 2022
TABLE 7 Global Oral Solid Dosage Contract Manufacturing Market, by Tablets, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Oral Solid Dosage Contract Manufacturing Market, by Tablets, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Oral Solid Dosage Contract Manufacturing Market, by Capsules, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Oral Solid Dosage Contract Manufacturing Market, by Capsules, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Oral Solid Dosage Contract Manufacturing Market, by Powders, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Oral Solid Dosage Contract Manufacturing Market, by Powders, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Oral Solid Dosage Contract Manufacturing Market, by Granules, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Oral Solid Dosage Contract Manufacturing Market, by Granules, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Oral Solid Dosage Contract Manufacturing Market, by Others, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Oral Solid Dosage Contract Manufacturing Market, by Others, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Oral Solid Dosage Contract Manufacturing Market, by Immediate-release, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Oral Solid Dosage Contract Manufacturing Market, by Immediate-release, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Oral Solid Dosage Contract Manufacturing Market, by Delayed-release, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Oral Solid Dosage Contract Manufacturing Market, by Delayed-release, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Oral Solid Dosage Contract Manufacturing Market, by Controlled-release, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Oral Solid Dosage Contract Manufacturing Market, by Controlled-release, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Oral Solid Dosage Contract Manufacturing Market, by Large-size Companies, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Oral Solid Dosage Contract Manufacturing Market, by Large-size Companies, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Oral Solid Dosage Contract Manufacturing Market, by Medium- & Small-size Companies, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Oral Solid Dosage Contract Manufacturing Market, by Medium- & Small-size Companies, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Oral Solid Dosage Contract Manufacturing Market, by Others, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Oral Solid Dosage Contract Manufacturing Market, by Others, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 30 Global Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 31 Global Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 32 Global Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 33 Global Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 34 Global Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 35 Global Oral Solid Dosage Contract Manufacturing Market, by Region, 2017-2022 (US$ Mn)
TABLE 36 Global Oral Solid Dosage Contract Manufacturing Market, by Region, 2023-2030 (US$ Mn)
TABLE 37 North America Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 38 North America Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 39 North America Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 40 North America Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 41 North America Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 42 North America Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 43 North America Oral Solid Dosage Contract Manufacturing Market, by Country, 2017-2022 (US$ Mn)
TABLE 44 North America Oral Solid Dosage Contract Manufacturing Market, by Country, 2023-2030 (US$ Mn)
TABLE 45 United States Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 46 United States Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 47 United States Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 48 United States Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 49 United States Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 50 United States Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 51 Canada Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 52 Canada Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 53 Canada Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 54 Canada Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 55 Canada Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 56 Canada Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 57 Mexico Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 58 Mexico Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 59 Mexico Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 60 Mexico Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 61 Mexico Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 62 Mexico Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 63 Europe Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 64 Europe Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 65 Europe Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 66 Europe Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 67 Europe Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 68 Europe Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 69 Europe Oral Solid Dosage Contract Manufacturing Market, by Country, 2017-2022 (US$ Mn)
TABLE 70 Europe Oral Solid Dosage Contract Manufacturing Market, by Country, 2023-2030 (US$ Mn)
TABLE 71 Germany Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 72 Germany Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 73 Germany Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 74 Germany Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 75 Germany Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 76 Germany Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 77 France Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 78 France Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 79 France Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 80 France Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 81 France Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 82 France Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 83 United Kingdom Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 84 United Kingdom Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 85 United Kingdom Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 86 United Kingdom Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 87 United Kingdom Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 88 United Kingdom Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 89 Italy Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 90 Italy Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 91 Italy Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 92 Italy Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 93 Italy Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 94 Italy Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 95 Spain Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 96 Spain Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 97 Spain Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 98 Spain Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 99 Spain Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 100 Spain Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 101 Rest of Europe Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 102 Rest of Europe Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 103 Rest of Europe Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 104 Rest of Europe Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 105 Rest of Europe Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 106 Rest of Europe Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 107 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 108 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 109 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 110 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 111 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 112 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 113 China Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 114 China Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 115 China Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 116 China Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 117 China Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 118 China Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 119 Japan Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 120 Japan Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 121 Japan Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 122 Japan Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 123 Japan Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 124 Japan Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 125 India Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 126 India Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 127 India Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 128 India Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 129 India Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 130 India Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 131 South Korea Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 132 South Korea Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 133 South Korea Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 134 South Korea Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 135 South Korea Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 136 South Korea Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 137 South-East Asia Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 138 South-East Asia Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 139 South-East Asia Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 140 South-East Asia Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 141 South-East Asia Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 142 South-East Asia Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 143 Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 144 Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 145 Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 146 Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 147 Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 148 Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 149 Latin America Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 150 Latin America Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 151 Latin America Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 152 Latin America Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 153 Latin America Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 154 Latin America Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 155 Brazil Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 156 Brazil Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 157 Brazil Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 158 Brazil Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 159 Brazil Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 160 Brazil Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 161 Argentina Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 162 Argentina Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 163 Argentina Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 164 Argentina Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 165 Argentina Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 166 Argentina Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 167 Rest of Latin America Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 168 Rest of Latin America Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 169 Rest of Latin America Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 170 Rest of Latin America Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 171 Rest of Latin America Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 172 Rest of Latin America Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 173 Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 174 Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 175 Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 176 Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 177 Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 178 Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 179 GCC Countries Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 180 GCC Countries Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 181 GCC Countries Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 182 GCC Countries Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 183 GCC Countries Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 184 GCC Countries Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 185 South Africa Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 186 South Africa Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 187 South Africa Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 188 South Africa Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 189 South Africa Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 190 South Africa Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)
TABLE 191 Rest of Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2017-2022 (US$ Mn)
TABLE 192 Rest of Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by Type Outlook, 2023-2030 (US$ Mn)
TABLE 193 Rest of Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2017-2022 (US$ Mn)
TABLE 194 Rest of Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by Modes of Sales, 2023-2030 (US$ Mn)
TABLE 195 Rest of Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2017-2022 (US$ Mn)
TABLE 196 Rest of Middle East and Africa Oral Solid Dosage Contract Manufacturing Market, by End-user Outlook, 2023-2030 (US$ Mn)

Frequently Asked Questions

What is the current size of the global oral solid dosage contract manufacturing market?

The global oral solid dosage contract manufacturing market was valued at USD 32.5 Billion in 2022.

What is the expected growth rate of the oral solid dosage contract manufacturing market between 2023 and 2030?

The oral solid dosage contract manufacturing market is expected to grow at a CAGR of 6.30% between 2023 and 2030, reaching USD 49.8 Billion in 2030.

Which segment is leading the market share in terms of type outlook?

Tablets is the leading segment by type outlook, holding over 32.7% share in terms of value in 2022.

Which mechanism outlook segment governs the world’s demand for oral solid dosage contract manufacturing?

The controlled-release segment governs the global demand for oral solid dosage contract manufacturing, holding a massive share of over 51.5% in 2022.

Which segment is expected to post the highest CAGR during the forecast period?

The medium- & small-size companies segment is expected to post the highest CAGR during the forecast period.

Which region is fueling the growth of the oral solid dosage contract manufacturing industry?

Asia Pacific is fueling the growth of the oral solid dosage contract manufacturing industry, with an over one-third share in 2022.

Who are the major global oral solid dosage contract manufacturing players?

The top players include Catalent Inc; Lonza Group; Piramal Pharma Solutions; Aenova; Jubilant; Boehringer Ingelheim; AbbVie Contract Manufacturing; Patheon; Recipharm; Next Pharma AB; Siegfried AG; Corden Pharma.

What are the major market drivers of the oral solid dosage contract manufacturing industry?

The major market drivers are increasing investments by CDMOs to extend the development of oral solid dosages and the development of drug delivery technologies such as targeted drug delivery and sustained release dosage forms.

What are the major market restraints of the oral solid dosage contract manufacturing industry?

Strict regulatory approval requirements are the major market restraints.

What are the major market opportunities of the oral solid dosage contract manufacturing industry?

Businesses already utilize cutting-edge technologies to increase the bioavailability of dosage forms to increase patient compliance, which are the major opportunities in the oral solid dosage contract manufacturing industry.

Healthcare

Trientine Hydrochloride Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 58081
Report Format: PDF
No of Pages: 247

Healthcare

Stretch Marks Treatment Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62116
Report Format: PDF
No of Pages: 221

Healthcare

Cirrhosis Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62114
Report Format: PDF
No of Pages: 229

Healthcare

Cryptococcal Meningitis Treatment Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62112
Report Format: PDF
No of Pages: 237

Healthcare

Dermatology Endoscopy devices Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62111
Report Format: PDF
No of Pages: 237

Healthcare

Cementless Total Knee Arthroplasty Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62110
Report Format: PDF
No of Pages: 228

Healthcare

Cell & Gene Therapy Clinical Trials Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62109
Report Format: PDF
No of Pages: 228

HealthCare

Self-sampling Blood Collection and Storage Device Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 61352
Report Format: PDF
No of Pages: 234

Healthcare

Used Oil Management Service Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 61355
Report Format: PDF
No of Pages: 227

Healthcare

Urothelial Cancer Treatment Market

Published Date: Sep. 2023
Category:  Healthcare
Report ID: 60931
Report Format: PDF
No of Pages: 231

Healthcare

Pharmaceutical Glass Tubing Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 61350
Report Format: PDF
No of Pages: 228

Healthcare

Prescription Dermatology Therapeutics Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 61347
Report Format: PDF
No of Pages: 238

Download Sample Report


Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
WhatsApp Now